Platelet transfusions from D+ donors to D- patients: A 10-year follow-up study of 1014 patients

Transfusion

Volumn 51, Issue 6, 2011, Pages 1163-1169

  Cid, Joan ^a,b   Carbassé, Gloria ^a   Pereira, Arturo ^a   Sanz, Cristina ^a   Mazzara, Roberto ^a   Escolar, Ginés ^a   Lozano, Miguel ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY; RHESUS D ANTIGEN; THROMBOCYTE CONCENTRATE;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY SCREENING; APHERESIS; ARTICLE; BLOOD DONOR; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RHESUS IMMUNIZATION; RHESUS INCOMPATIBILITY; SCHOOL CHILD; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ISOANTIBODIES; MALE; MIDDLE AGED; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79958776269     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02953.x     Document Type: Article

References (47)

1. European Committee on Blood Transfusion. Guide to the preparation, use and quality assurance of blood components. 15th ed. Strasbourg: EDQM; 2010.
2. Brecher ME, Leger RM, Linden JV, Roseff SD,. Technical manual. 15th ed. Bethesda, MA: AABB Press; 2005.
3. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH,. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1519-38. (Pubitemid 32202560)
4. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122: 10-23.
5. Menitove JE,. Immunoprophylaxis for D- patients receiving platelet transfusions from D+[correction of D-] donors? Transfusion 2002; 42: 136-8.
6. Cid J, Ortin X, Elies E, Castella D, Panades M, Martin-Vega C,. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002; 42: 173-6.
7. Cid J,. PLT transfusions from D+ blood donors to D- patients with hematologic diseases: am update. Transfusion 2003; 43: 1759-60. (Pubitemid 37518086)
8. Cid J, Claparols M, Pinacho A, Hernandez JM, Ortiz P, Puig LS, Pla RP,. Comparison of blood component preparation methods from whole blood bags based on buffy coat extraction. Transfus Apher Sci 2007; 36: 243-7. (Pubitemid 47096813)
9. Summary of the quality control of blood components. 2010. [cited 2010 June 2]. Available from: URL
10. Cid J, Nogues N, Montero R, Hurtado M, Briega A, Parra R,. Comparison of three microtube column agglutination systems for antibody screening: DG Gel, DiaMed-ID and Ortho BioVue. Transfus Med 2006; 16: 131-6. (Pubitemid 43935069)
11. Lozano M, Cid J,. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003; 17: 57-68. (Pubitemid 36042645)
12. Goldfinger D, McGinniss MH,. Rh-incompatible platelet transfusions-risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971; 284: 942-4.
13. Baldwin ML, Ness PM, Scott D, Braine H, Kickler TS,. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion 1988; 28: 330-3.
14. McLeod BC, Piehl MR, Sassetti RJ,. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients. Vox Sang 1990; 59: 185-9. (Pubitemid 20332877)
15. Heim MU, Bock M, Kolb HJ, Schleuning M, Mempel W,. Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases. Vox Sang 1992; 62: 165-8.
16. Lichtiger B, Surgeon J, Rhorer S,. Rh-incompatible platelet transfusion therapy in cancer patients. A study of 30 cases. Vox Sang 1983; 45: 139-43. (Pubitemid 13071853)
17. Zeiler T, Wittmann G, Zingsem J, Weisbach V, Zimmermann R, Eckstein R,. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion. Vox Sang 1994; 66: 243. (Pubitemid 24103664)
18. Atoyebi W, Mundy N, Croxton T, Littlewood TJ, Murphy MF,. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000; 111: 980-3. (Pubitemid 32098939)
19. Molnar R, Johnson R, Sweat LT, Geiger TL,. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002; 42: 177-82.
20. Misso S, Feola B, Paesano L, D'Onofrio M, Fratellanza G, D'Agostino E, Nigro M, Minerva A, Formisano S,. Anti-D alloimmunisation following Rh-incompatible platelet transfusions. Blood Transfus 2006; 4: 102-5. (Pubitemid 352026034)
21. Bartley AN, Carpenter JB, Berg MP,. D+ platelet transfusions in D- patients: cause for concern? Immunohematology. 2009; 25: 5-8.
22. Cid J, Lozano M,. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients. Transfusion 2005; 45: 453-4. (Pubitemid 40389443)
23. Klein HG, Anstee DJ,. Blood transfusion in clinical medicine. 11th ed. London: Blackwell Publishing; 2005.
24. Cid J, Lozano M, Fernandez-Aviles F, Carreras E, Pereira A, Mazzara R, Ordinas A,. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Transfusion 2006; 46: 169-73. (Pubitemid 43381749)
25. Boctor FN, Ali NM, Mohandas K, Uehlinger J,. Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion 2003; 43: 173-6. (Pubitemid 36207296)
26. Yuan S, Davis R, Lu Q, Goldfinger D, Ziman AF,. Low risk of alloimmunization to the D antigen in D- orthotopic liver transplant recipients receiving D+ RBCs perioperatively. Transfusion 2008; 48: 2653-5.
27. Casanueva M, Valdes MD, Ribera MC,. Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion 1994; 34: 570-2. (Pubitemid 24246133)
28. Frohn C, Dumbgen L, Brand JM, Gorg S, Luhm J, Kirchner H,. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003; 43: 893-8. (Pubitemid 36753939)
29. Gonzalez-Porras JR, Graciani IF, Perez-Simon JA, Martin-Sanchez J, Encinas C, Conde MP, Nieto MJ, Corral M,. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion 2008; 48: 1318-24.
30. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Jr, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, Karl IE,. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166: 6952-63. (Pubitemid 32467243)
31. Puyana JC, Pellegrini JD, De AK, Kodys K, Silva WE, Miller CL,. Both T-helper-1- and T-helper-2-type lymphokines are depressed in posttrauma anergy. J Trauma 1998; 44: 1037-45.
32. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W, Wagner H, Siewert JR, Holzmann B,. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 1997; 65: 2283-91. (Pubitemid 27237311)
33. Yazer MH, Triulzi DJ,. Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion 2007; 47: 2197-201. (Pubitemid 350151195)
34. Dutton RP, Shih D, Edelman BB, Hess J, Scalea TM,. Safety of uncrossmatched type-O red cells for resuscitation from hemorrhagic shock. J Trauma 2005; 59: 1445-9.
35. Cid J, Ramiro L,. Anti-D alloimmunization after transfusion of D+ red blood cells. Transfusion 2009; 49: 186-7.
36. Starzl TE, Zinkernagel RM,. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998; 339: 1905-13. (Pubitemid 29013935)
37. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP,. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999; 93: 3127-39. (Pubitemid 29200808)
38. Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, Owings JT, Holland PV, Busch MP,. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 2005; 45: 1280-90. (Pubitemid 41647791)
39. Mincheff MS, Meryman HT, Kapoor V, Alsop P, Wotzel M,. Blood transfusion and immunomodulation: a possible mechanism. Vox Sang 1993; 65: 18-24. (Pubitemid 23212382)
40. Mincheff MS, Getsov SI, Meryman HT,. Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model. Transplantation 1995; 60: 815-21.
41. Mincheff MS, Meryman HT,. Blood transfusion, blood storage and immunomodulation. Immunol Invest 1995; 24: 303-9.
42. Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE,. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 2004; 103: 333-9. (Pubitemid 38029957)
43. Vamvakas EC, Blajchman MA,. Universal WBC reduction: the case for and against. Transfusion 2001; 41: 691-712. (Pubitemid 32845014)
44. Schonewille H, Brand A,. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol 2005; 129: 151-6. (Pubitemid 40524063)
45. Blumberg N, Heal JM, Gettings KF,. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 2003; 43: 945-52. (Pubitemid 36753945)
46. Yazer MH, Triulzi DJ, Shaz B, Kraus T, Zimring JC,. Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? Transfusion 2009; 49: 1070-5.
47. Young NT, Street J, Darke C,. Immunoglobulin allotype frequencies in responders and nonresponders to the Rh(D) antigen. Exp Clin Immunogenet 1995; 12: 88-91.